Literature DB >> 9930677

Absolute conservation of residue 6 of immunoglobulin heavy chain variable regions of class IIA is required for correct folding.

H J de Haard1, B Kazemier, A van der Bent, P Oudshoorn, P Boender, B van Gemen, J W Arends, H R Hoogenboom.   

Abstract

While studying the expression of single-chain antibodies (scFv) derived from several murine monoclonal antibodies, we found that residue 6 in Framework region 1 of the heavy chain variable domain plays a crucial role in antibody folding. Binding activity of three murine antibodies with a heavy chain variable region (VH) subgroup IIA was completely lost when at this position the wild-type residue glutamine (Q) was substituted by glutamate (E). Increased sensitivity towards trypsin digestion of soluble scFv suggested that the lack of binding activity was caused by incorrect folding of Q6E mutants. Grafting of the three additional class IA derived FR1 residues, based upon the comparison between both classes of VH sequences, on to the 'defect' subgroup IIA sequence, partially restored the antigen binding activity of the Q6E-containing scFv. Our results suggest that residue 6 of the heavy chain may be part of a folding nucleus, involving the first two beta-strands of Framework region 1. The evolutionary conservation of either glutamine or glutamate at position 6 in different antibody families may well indicate that within immunoglobulin VH domains, different family specific folding nuclei have evolved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9930677     DOI: 10.1093/protein/11.12.1267

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  9 in total

1.  N-terminal mutations in the anti-estradiol Fab 57-2 modify its hapten binding properties.

Authors:  P Saviranta PJauria; U Lamminmäki; J Hellman; S Eriksson; T Lövgren
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

2.  Conversion of scFv peptide-binding specificity for crystal chaperone development.

Authors:  Jennifer C Pai; Jeffrey A Culver; Jason E Drury; Rakesh S Motani; Raquel L Lieberman; Jennifer A Maynard
Journal:  Protein Eng Des Sel       Date:  2011-01-08       Impact factor: 1.650

3.  Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans.

Authors:  Colin F Greineder; Elizabeth D Hood; Anning Yao; Makan Khoshnejad; Jake S Brenner; Ian H Johnston; Mortimer Poncz; Claudia Gottstein; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2016-02-06       Impact factor: 9.776

4.  Efficient isolation of soluble intracellular single-chain antibodies using the twin-arginine translocation machinery.

Authors:  Adam C Fisher; Matthew P DeLisa
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

5.  Antibody engineering using phage display with a coiled-coil heterodimeric Fv antibody fragment.

Authors:  Xinwei Wang; Pinyu Zhong; Peter P Luo; Kevin C Wang
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

Review 6.  Botulinum neurotoxins and botulism: a novel therapeutic approach.

Authors:  Jeeraphong Thanongsaksrikul; Wanpen Chaicumpa
Journal:  Toxins (Basel)       Date:  2011-05-13       Impact factor: 4.546

7.  Oligonucleotide-assisted cleavage and ligation: a novel directional DNA cloning technology to capture cDNAs. Application in the construction of a human immune antibody phage-display library.

Authors:  Sonia Schoonbroodt; Nicolas Frans; Mark DeSouza; Rachel Eren; Smadar Priel; Naama Brosh; Judith Ben-Porath; Arie Zauberman; Ehud Ilan; Shlomo Dagan; Edward H Cohen; Hennie R Hoogenboom; Robert Charles Ladner; René M Hoet
Journal:  Nucleic Acids Res       Date:  2005-05-19       Impact factor: 16.971

8.  Fast track antibody V-gene rescue, recombinant expression in plants and characterization of a PfMSP4-specific antibody.

Authors:  Stephanie Kapelski; Alexander Boes; Holger Spiegel; Melanie de Almeida; Torsten Klockenbring; Andreas Reimann; Rainer Fischer; Stefan Barth; Rolf Fendel
Journal:  Malar J       Date:  2015-02-05       Impact factor: 2.979

9.  A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain.

Authors:  Ghasidit Pornnoppadol; Boya Zhang; Alec A Desai; Anthony Berardi; Henriette A Remmer; Peter M Tessier; Colin F Greineder
Journal:  PLoS One       Date:  2021-10-11       Impact factor: 3.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.